The groundbreaking success of Sildenafil undeniably transformed the drug landscape, but investing in companies heavily reliant on generic versions presents a challenging picture. Although early earnings were https://pharma963747.blogkoo.com/sildenafil-and-pharma-a-risky-stake-61551437